FDA Adverse Event Malfunction Summary report: N

VITROS IMMUNODIAGNOSTIC PRODUCTS TROPONIN I ES REAGENT PACK

MDR report key: 2882223 · Received December 20, 2012

Report

Report Number
3007111389-2012-00256
Event Type
Malfunction
Date Received
December 20, 2012
Date of Event
December 3, 2012
Report Date
December 20, 2012
Manufacturer
ORTHO-CLINICAL DIAGNOSTICS
Product Code
MMI
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
VA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE INVESTIGATION DETERMINED THAT A NON-REPRODUCIBLE, HIGHER THAN EXPECTED VITROS TROP I ES RESULT WAS OBTAINED FROM A SINGLE PATIENT RUN ON THE VITROS 5600 SYSTEM. THERE WAS NO EVIDENCE TO SUGGEST AN INSTRUMENT/ REAGENT MALFUNCTION HAD OCCURRED. ADDITIONALLY, THE SAMPLE WAS NOT PROCESSED IN ACCORDANCE WITH THE TUBE MANUFACTURER'S RECOMMENDATIONS. IT IS LIKELY THAT CELLULAR DEBRIS, DUE TO POOR SAMPLE PREPARATION, WAS PRESENT IN THE AFFECTED SAMPLE, ALTHOUGH THIS COULD NOT BE CONFIRMED. A DEFINITIVE ROOT CAUSE FOR THE EVENT COULD NOT BE DETERMINED. HOWEVER, A PRE-ANALYTICAL SAMPLE PROCESSING ISSUE COULD NOT BE RULED OUT AS A CONTRIBUTING FACTOR.

Description of Event or Problem · 1

THE CUSTOMER OBTAINED A NON-REPRODUCIBLE, HIGHER THAN EXPECTED VITROS TROP I ES RESULT (0.148 VS. EXPECTED RESULTS <0.012 NG/ML) FROM A SINGLE PATIENT RUN ON THE VITROS 5600 SYSTEM. BIASED RESULTS OF THE MAGNITUDE AND DIRECTION OBSERVED MAY LEAD TO INAPPROPRIATE PHYSICIAN ACTION. HOWEVER, THE HIGHER THAN EXPECTED RESULT WAS NOT REPORTED FROM THE LABORATORY. THE CUSTOMER RETESTED THE SAMPLE IN DUPLICATES PER CUSTOMER POLICY PRIOR TO REPORTING. THERE WAS NO ALLEGATION OF PATIENT HARM AS A RESULT OF THIS EVENT. (B)(4).

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 VITROS IMMUNODIAGNOSTIC PRODUCTS TROPONIN I ES REAGENT PACK IN-VITRO DIAGNOSTIC MMI ORTHO-CLINICAL DIAGNOSTICS 1000

Patients

Seq Age Sex Outcome Treatment
1